PharmGKB summary: very important pharmacogene information for CYP1A2.
about
Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay.Bioinformatics and variability in drug response: a protein structural perspective.Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs.Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations.Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean.The Rationale for and Clinical Pharmacology of Prasugrel 5 mg.Lack of effect of smoking status on axitinib pharmacokinetics in patients with non-small-cell lung cancer.Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior.Polymorphisms of CYP1A2 and CYP2A6 activity: phenotypes and the effect of age and sex in a Nigerian population.Genetic polymorphism analysis of the drug-metabolizing enzyme CYP1A2 in a Uyghur Chinese population: a pilot study.Pharmacogenetic Analysis of the Model-Based Pharmacokinetics of Five Anti-HIV Drugs: How Does This Influence the Effect of Aging?The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report.Identifying clinically relevant sources of variability: The clopidogrel challenge.CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy.
P2860
Q34430684-8AA8A098-7141-48BD-87A9-8183E43A408DQ36009999-98D22FA9-6DAD-430F-B36C-839E7548FC50Q36460560-AE966979-9744-453B-8B37-D8F756B5A04CQ37344778-5210CC68-BE7A-42D4-A7CF-C7E858797A26Q37344782-7454FF73-81FA-4B58-A107-9B5BAC7A3CD1Q38447706-67D43A06-9AD9-4109-86E0-01DF4B3DD542Q39010701-8C927DD6-43A2-44E2-990E-63F5F1F44C83Q39248181-70A2DB3A-FDCD-4986-869A-E7D20058E04AQ40554461-8455E4D1-1068-46C0-B5CA-FFBC37023C0AQ40812008-7002CCCD-B79A-41C9-8346-1E4AFD1D2B80Q44038091-5F0EAFE9-3909-42A3-9511-17CB0A247329Q44877659-EEB79329-DDF1-4D83-B5DA-F2551D2B3CBBQ48037601-F8092A6C-5956-40CD-81DF-10C73F50F190Q50591900-4A5D9344-27D2-4D81-8A57-F901EB18B13BQ50736062-953ACD66-08FB-4E07-B8FF-F5D59856C898
P2860
PharmGKB summary: very important pharmacogene information for CYP1A2.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PharmGKB summary: very important pharmacogene information for CYP1A2.
@ast
PharmGKB summary: very important pharmacogene information for CYP1A2.
@en
type
label
PharmGKB summary: very important pharmacogene information for CYP1A2.
@ast
PharmGKB summary: very important pharmacogene information for CYP1A2.
@en
prefLabel
PharmGKB summary: very important pharmacogene information for CYP1A2.
@ast
PharmGKB summary: very important pharmacogene information for CYP1A2.
@en
P2860
P1476
PharmGKB summary: very important pharmacogene information for CYP1A2.
@en
P2093
Caroline F Thorn
Teri E Klein
P2860
P356
10.1097/FPC.0B013E32834C6EFD
P577
2012-01-01T00:00:00Z